Emergent Biosolutions Inc. buy melinda
Start price
24.06.11
/
50%
€15.32
Target price
26.12.11
€18.00
Performance (%)
-15.00%
End price
26.12.11
€13.02
Summary
This prediction ended on 26.12.11 with a price of €13.02. The price of Emergent Biosolutions Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.00%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Emergent Biosolutions Inc. | -6.344% | -6.344% | -43.968% | -90.523% |
| iShares Core DAX® | -0.654% | 1.989% | 14.984% | 18.052% |
| iShares Nasdaq 100 | 0.903% | 5.664% | 36.140% | 58.351% |
| iShares Nikkei 225® | -0.740% | -1.363% | 10.792% | 6.321% |
| iShares S&P 500 | -0.013% | 3.020% | 28.126% | 48.476% |
According to melinda what are the pros and cons of Emergent Biosolutions Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
biopharmazeutisches
Emergent BioSolutions entwickelt und vermarktet seine Produkte über ein Portfolio von innovativen Impfstoffen, dass Infektionskrankheiten in der Welt Ziel
(Laufzeit überschritten)
Stopped prediction by melinda for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€7.26
23.03.23
23.03.23
€11.00
23.03.24
23.03.24
-79.47%
13.02.24
13.02.24
Could be worthwhile Investment >10% per year
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€50.50
28.01.20
28.01.20
€55.00
04.11.21
04.11.21
-23.09%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year